| 000 | 01655 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513232142.0 | ||
| 264 | 0 | _c20010308 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0041-1337 | ||
| 024 | 7 |
_a10.1097/00007890-200101270-00017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCotler, S J | |
| 245 | 0 | 0 |
_aDaily interferon therapy for hepatitis C virus infection in liver transplant recipients. _h[electronic resource] |
| 260 |
_bTransplantation _cJan 2001 |
||
| 300 |
_a261-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aFatigue _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver _xpathology |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGanger, D R | |
| 700 | 1 | _aKaur, S | |
| 700 | 1 | _aRosenblate, H | |
| 700 | 1 | _aJakate, S | |
| 700 | 1 | _aSullivan, D G | |
| 700 | 1 | _aNg, K W | |
| 700 | 1 | _aGretch, D R | |
| 700 | 1 | _aJensen, D M | |
| 773 | 0 |
_tTransplantation _gvol. 71 _gno. 2 _gp. 261-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007890-200101270-00017 _zAvailable from publisher's website |
| 999 |
_c11150966 _d11150966 |
||